Prathipati, P., Pathania, A. S., Chaturvedi, N. K., Gupta, S. C., Byrareddy, S. N., Coulter, D. W., & Challagundla, K. B. (2024). SAP30, an oncogenic driver of progression, poor survival, and drug resistance in neuroblastoma. Molecular Therapy: Nucleic Acids, 35(2), . https://doi.org/10.1016/j.omtn.2022.03.014
Chicago-referens (17:e uppl.)Prathipati, Philip, Anup S. Pathania, Nagendra K. Chaturvedi, Subash C. Gupta, Siddappa N. Byrareddy, Don W. Coulter, och Kishore B. Challagundla. "SAP30, an Oncogenic Driver of Progression, Poor Survival, and Drug Resistance in Neuroblastoma." Molecular Therapy: Nucleic Acids 35, no. 2 (2024). https://doi.org/10.1016/j.omtn.2022.03.014.
MLA-referens (9:e uppl.)Prathipati, Philip, et al. "SAP30, an Oncogenic Driver of Progression, Poor Survival, and Drug Resistance in Neuroblastoma." Molecular Therapy: Nucleic Acids, vol. 35, no. 2, 2024, https://doi.org/10.1016/j.omtn.2022.03.014.
